- £82.35m
- £91.41m
- £1.69m
Posting of Circular and Notice of General Meeting
Proposed Retail Offer
Brief: 4basebio Conditionally Raises Gross Proceeds Of £15 Million
Results of Capital Raise
Brief: 4Basebio Proposes Capital Raise Of New Ordinary Shares To Raise Not Less Than £15 Million
Proposed Capital Raise of New Ordinary Shares to raise not less than £15 million
Half-year Report
4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company's Phase I Cell Therapy Program
4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine
Brief: 4Basebio Enters Into Strategic Collaboration And Marketing Agreement With Genezen
4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing
Grant of Options & Director/PDMR Dealing
Director Appointment
Brief: 4Basebio To Seek Shareholder Approval For Substantial Intellectual Property Disposal
Notice of Annual General Meeting
Director Dealing
Brief: 4basebio Signs Clinical Supply Agreement To Support Phase II Clinical Trial
Final Results and Notice of AGM
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial